Tradestie Institutional Equity Comparison Engine

SGMT vs CAMP โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SGMT Overall Edge

SGMT Captures Institutional Edge (3โ€“0 Pillars ยท 6โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sagimet Biosciences Inc. Series A Common Stock (SGMT) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, SGMT trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus CAMP at N/M Forward P/E and -991.8% operating margin (+138.9% YoY). In options structure, SGMT sits in BREAKOUT (5th %ile IV; Dealer Gamma Walls on Pro) against CAMP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
SGMT N/M vs CAMP N/M Fwd P/E
Growth & Margin Winner SGMT
Op Margin 0.0% vs -991.8% ยท YoY +0.0% vs +138.9%
Momentum & Technical Winner SGMT
1Y +26.1% vs -2.4% ยท 52W Pos 76% vs 23%
Options & Structure Winner SGMT
BREAKOUT (5th %ile IV) vs UNCLASSIFIED (N/A IV)
SGMT NASDAQ
Sagimet Biosciences Inc. Series A Common Stock
Pharmaceutical Preparations
$9.78
-3.5% 1D
Market Cap $735.2M
1M Return +10.33%
1Y Return +26.13%
Forward P/E N/M
Unified AI Score
52.6 / 100 HOLD
Tech 36.0 Fund 54.0 Flow 69.0 Mom 60.0
CAMP NASDAQ
CAMP4 Therapeutics Corporation Common Stock
Pharmaceutical Preparations
$4.00
+3.63% 1D
Market Cap $238.5M
1M Return +27.39%
1Y Return -2.44%
Forward P/E N/M
Unified AI Score
43.9 / 100 HOLD
Tech 34.0 Fund 40.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SGMT +26.13% CAMP -2.44% Spread: +28.57 pp (SGMT Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period SGMT Revenue CAMP Revenue SGMT Op. Margin CAMP Op. Margin Margin Edge
FY2023 $0M $0M -1537.0% -14822.6% SGMT
FY2024 N/A $0M N/A -8142.3% CAMP
FY2025 N/A $0M N/A -1502.4% CAMP

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SGMT (6) vs CAMP (1)
Institutional Metric SGMT CAMP Criterion Row Winner
Market Capitalization Scale $735.2M $238.5M Larger Scale SGMT
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +138.9% Higher Growth CAMP
Operating Margin (TTM) Profitability 0.0% -991.8% Higher Margin SGMT
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -29.5% -146.1% Higher ROE SGMT
52-Week Range Position Momentum 76% ($4โ€“$11) 23% ($3โ€“$8) Stronger Trend SGMT
Beta / 30D Volatility Risk Regime 2.08ฮฒ ยท 84% Vol 1.35ฮฒ ยท 94% Vol Lower Realized Risk SGMT
Unified Institutional Score Composite Signal 52.6 / 100 (HOLD) 43.9 / 100 (HOLD) Higher Composite SGMT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SGMT vs CAMP Buy Guide
SGMT BREAKOUT
141d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live SGMT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CAMP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CAMP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SGMT nor CAMP registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.